25.05. | CENTOGENE N : CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms.. |  |
25.05. | CENTOGENE's CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platform.. |  |
23.05. | CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequ.. |  |
23.05. | CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequ.. |  |
23.05. | CENTOGENE N : Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Seq.. |  |
19.05. | CENTOGENE to Present at the H.C. Wainwright Global Investment Conference |  |
19.05. | CENTOGENE to Present at the H.C. Wainwright Global Investment Conference |  |
03.05. | Centogene N.V. Announces Resignation of Volkmar Weckesser as Chief Information Officer .. |  |
28.04. | CENTOGENE N : and Takeda Extend Market Access and Expansion Partnership to Advance Patient.. |  |
28.04. | CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient .. |  |
28.04. | Centogene N.V. and Takeda Extend Market Access and Expansion Partnership to Advance Pat.. |  |
21.04. | CENTOGENE N : Minutes of the February 2022 EGM |  |
31.03. | Centogene N.V. Reports Earnings Results for the Full Year Ended December 31, 2021 |  |
30.03. | CENTOGENE N : Reports Fourth Quarter and Fiscal Year 2021 Financial Results - Form 6-K |  |
30.03. | TRANSCRIPT : Centogene N.V., Q4 2021 Earnings Call, Mar 30, 2022 |  |
30.03. | CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results |  |
30.03. | Centogene N.V. Provides Earnings Guidance for the Year 2022 |  |
24.03. | CENTOGENE N : MEDIA RELEASE - Form 6-K |  |
24.03. | CENTOGENE CEO Kim Stratton to Speak at BIO-Europe Spring® 2022 Conference |  |
23.03. | Top Premarket Decliners |  |
23.03. | CENTOGENE N : to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 3.. |  |
23.03. | CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30.. |  |
17.03. | CENTOGENE N : Announces Expansion of Data Access and Collaboration Agreement With Pfizer -.. |  |
17.03. | CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer |  |
22.02. | CENTOGENE Announces Voting Results of Extraordinary General Meeting |  |
22.02. | CENTOGENE N : Announces Voting Results of Extraordinary General Meeting - Form 6-K |  |
22.02. | MBMV invests in international bio-tech startup Arcensus GmbH |  |
08.02. | Centogene Chief Financial Officer to Resign; Miguel Coego Rios Named as Interim CFO |  |
08.02. | CENTOGENE N : Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance.. |  |
08.02. | CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance .. |  |
08.02. | Centogene N.V. Announces Chief Financial Officer Transition |  |
08.02. | Centogene N.V. Appoints Miguel Coego Rios as Executive Vice President of Finance & Lega.. |  |
03.02. | CENTOGENE N : CONVENING NOTICE - Form 6-K |  |
01.02. | CENTOGENE N : Announces USD 62 Million Aggregate Equity and Debt Financings to Support Gro.. |  |
01.02. | Centogene Appoints Kim Stratton as Permanent Chief Executive Officer |  |
01.02. | CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board |  |
01.02. | CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Grow.. |  |
01.02. | CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer |  |
01.02. | Centogene Nominates Kim Stratton as Chief Executive Officer |  |
01.02. | Centogene N.V. announced that it has received 14.915363 million in funding from D.. |  |
20.01. | CENTOGENE N : Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Ta.. |  |
20.01. | CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Tar.. |  |
20.01. | Centogene N.V. and Insilico Medicine Announces Research and Development Collaboration t.. |  |
12.01. | Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO |  |
04.01. | Centogene Rolls Out SaaS Platform for Laboratories |  |
04.01. | CENTOGENE N : CentoCloud® Set to Revolutionize Rare Disease Diagnostics With Decentralized.. |  |
04.01. | CENTOGENE's CentoCloud® Set to Revolutionize Rare Disease Diagnostics With Decentralize.. |  |
04.01. | Centogene N.V. Announces the Global Release of CentoCloud, A SaaS Platform Enabling Dec.. |  |
2021 | CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) .. |  |
2021 | OPINIONES DE LOS ANALISTAS DEL DÍA : Tesla, Ryanair, Suse, Knorr-Bremse, BioNTech, Metro A.. |  |
2021 | BOLSA DE MADRID : El mercado quiere su rally bajo el árbol |  |
2021 | Centogene CEO Andrin Oswald to Take Medical Leave; Interim CEO Named |  |
2021 | CENTOGENE N : Announces CEO to Take Temporary Medical Leave of Absence – Biopharmace.. |  |
2021 | CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceu.. |  |
2021 | Centogene N.V. Announces Executive Changes |  |
2021 | Centogene Shares Sink on Wider Q3 Loss, Lower Revenue -- Shares Sink |  |
2021 | Top Midday Decliners |  |
2021 | Centogene Q3 Loss Expands as Revenue Slides |  |
2021 | TRANSCRIPT : Centogene N.V., Q3 2021 Earnings Call, Nov 24, 2021 |  |
2021 | CENTOGENE N : Reports Third Quarter 2021 Financial Results - Form 6-K |  |
2021 | Centogene N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep.. |  |
2021 | CENTOGENE Reports Third Quarter 2021 Financial Results |  |
2021 | Centogene N.V. Provides Earnings Guidance for the Full Year 2021 |  |
2021 | CENTOGENE N : to Announce Third Quarter 2021 Financial Results on November 24, 2021 - Form.. |  |
2021 | CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021 |  |
2021 | CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021 |  |
2021 | TRANSCRIPT : Centogene N.V. Presents at 30th Annual Credit Suisse Healthcare Conference, N.. |  |
2021 | CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Dis.. |  |
2021 | CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Dis.. |  |
2021 | CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study - Form .. |  |
2021 | CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study |  |
2021 | Centogene N.V. Enrolls First Patient in Frontotemporal Dementia Clinical Study |  |
2021 | CENTOGENE N : Twist Bioscience Joint Forces to Develop Advanced Sequencing Tools for Rare .. |  |
2021 | CENTOGENE N : and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Te.. |  |
2021 | CENTOGENE N : and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Te.. |  |